Corcept Therapeutics (CORT) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 137.65% |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn | -463.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -463.76% |
| Dec 31, 2025 | -35.94% |
| Sep 30, 2025 | -23.97% |
| Jun 30, 2025 | 8.51% |
| Mar 31, 2025 | -80.36% |
| Dec 31, 2024 | 984.05% |
| Sep 30, 2024 | 35.53% |
| Jun 30, 2024 | -3.35% |
| Mar 31, 2024 | -8.48% |
| Dec 31, 2023 | -83.42% |
| Sep 30, 2023 | 58.79% |
| Jun 30, 2023 | 134.08% |
| Mar 31, 2023 | -26.33% |
| Dec 31, 2022 | -32.42% |
| Sep 30, 2022 | -31.41% |
| Jun 30, 2022 | -59.25% |
| Mar 31, 2022 | 39.29% |
| Dec 31, 2021 | 42.50% |
| Sep 30, 2021 | 63.31% |
| Jun 30, 2021 | -16.78% |
| Mar 31, 2021 | -23.87% |
| Dec 31, 2020 | -28.31% |
| Sep 30, 2020 | -22.06% |
| Jun 30, 2020 | 111.33% |
| Mar 31, 2020 | 41.85% |
| Dec 31, 2019 | 125.73% |
| Sep 30, 2019 | -14.21% |
| Jun 30, 2019 | 66.00% |
| Mar 31, 2019 | -31.81% |
| Dec 31, 2018 | -13.87% |
| Sep 30, 2018 | 310.03% |
| Jun 30, 2018 | -1.43% |
| Mar 31, 2018 | 263.49% |
| Dec 31, 2017 | 453.05% |
| Sep 30, 2017 | 22.59% |
| Jun 30, 2017 | 870.81% |
| Mar 31, 2017 | 188.58% |
| Dec 31, 2016 | 7.51% |
| Sep 30, 2016 | 901.70% |
| Jun 30, 2016 | 1,238.85% |
| Mar 31, 2016 | 280.84% |
| Dec 31, 2015 | 397.93% |
| Sep 30, 2015 | 114.85% |
| Jun 30, 2015 | 98.46% |
| Mar 31, 2015 | 83.79% |
| Dec 31, 2014 | 81.79% |
| Sep 30, 2014 | 31.41% |
| Jun 30, 2014 | 2.25% |
| Mar 31, 2014 | 3.47% |
| Dec 31, 2013 | 12.43% |
| Sep 30, 2013 | 6.62% |
| Jun 30, 2013 | -16.58% |
| Mar 31, 2013 | -13.85% |
| Dec 31, 2012 | -39.82% |
| Sep 30, 2012 | -40.54% |
| Jun 30, 2012 | -9.98% |
| Mar 31, 2012 | -39.33% |
| Dec 31, 2011 | -15.38% |
| Sep 30, 2011 | -2.77% |